Clozapine-induced Gastrointestinal Hypomotility--New Objective Evidence for an Underestimated Side-effect.
作者信息
Hasan Alkomiet
机构信息
Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany.
出版信息
EBioMedicine. 2016 Feb 27;5:12-3. doi: 10.1016/j.ebiom.2016.02.037. eCollection 2016 Mar.
Abstract
摘要
相似文献
1
Clozapine-induced Gastrointestinal Hypomotility--New Objective Evidence for an Underestimated Side-effect.氯氮平引起的胃肠动力不足——一种被低估的副作用的新客观证据。
EBioMedicine. 2016 Feb 27;5:12-3. doi: 10.1016/j.ebiom.2016.02.037. eCollection 2016 Mar.
2
Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine.轻度至中度氯氮平引起的胃肠道动力不足通常不需要停用氯氮平。
Gen Hosp Psychiatry. 2017 Sep;48:72-73. doi: 10.1016/j.genhosppsych.2017.06.007. Epub 2017 Jun 16.
3
Response to: Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine.回应：轻度至中度氯氮平引起的胃肠动力不足不应要求停用氯氮平。
Gen Hosp Psychiatry. 2017 Sep;48:74. doi: 10.1016/j.genhosppsych.2017.06.004. Epub 2017 Jun 20.
4
Clozapine-induced gastrointestinal hypomotility.氯氮平引起的胃肠道动力不足。
Australas Psychiatry. 2011 Oct;19(5):450-1. doi: 10.3109/10398562.2011.610462.
5
Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.氯氮平所致胃肠道动力不足：一项为期22年的双国家严重或致命“肠道迟缓”反应药物警戒研究，并与国际药品安全建议进行比较
CNS Drugs. 2017 Aug;31(8):699-709. doi: 10.1007/s40263-017-0448-6.
6
Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.聚焦基础：评估和治疗氯氮平引起的胃肠道动力不足。
Int J Psychiatry Clin Pract. 2020 Mar;24(1):18-19. doi: 10.1080/13651501.2019.1710538. Epub 2020 Jan 7.
7
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.危及生命的氯氮平所致胃肠道动力不足：102例分析
J Clin Psychiatry. 2008 May;69(5):759-68. doi: 10.4088/jcp.v69n0509.
8
Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.报告加拿大氯氮平引起的胃肠动力低下和与致命结局相关的因素：药物警戒数据库研究。
Psychiatry Res. 2020 Aug;290:113048. doi: 10.1016/j.psychres.2020.113048. Epub 2020 May 16.
9
Clozapine induced gastrointestinal hypomotility: A potentially life threatening adverse event. A review of the literature.氯氮平诱发胃肠道动力不足：一种潜在的危及生命的不良事件。文献综述
Gen Hosp Psychiatry. 2017 May;46:32-37. doi: 10.1016/j.genhosppsych.2017.02.004. Epub 2017 Feb 28.
10
Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.氯氮平对肠道的影响：胃排空延迟和小肠及大肠运动障碍的横断面研究。
CNS Drugs. 2019 Jan;33(1):81-91. doi: 10.1007/s40263-018-0587-4.
引用本文的文献
1
Pharmacological treatment for antipsychotic-related constipation.抗精神病药物相关性便秘的药物治疗。
Cochrane Database Syst Rev. 2017 Jan 24;1(1):CD011128. doi: 10.1002/14651858.CD011128.pub2.
本文引用的文献
1
Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study.氯氮平治疗的患者存在明显的胃肠动力不足，这可能是危及生命的胃肠道并发症的基础：一项横断面研究。
EBioMedicine. 2016 Feb 15;5:125-34. doi: 10.1016/j.ebiom.2016.02.020. eCollection 2016 Mar.
2
Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.氯氮平与标准抗精神病药物治疗成人精神分裂症的疗效比较。
Am J Psychiatry. 2016 Feb 1;173(2):166-73. doi: 10.1176/appi.ajp.2015.15030332. Epub 2015 Nov 6.
3
Rare and very rare adverse effects of clozapine.氯氮平的罕见和极罕见不良反应。
Neuropsychiatr Dis Treat. 2015 Aug 6;11:1995-2003. doi: 10.2147/NDT.S83989. eCollection 2015.
4
Clozapine's role in the treatment of first-episode schizophrenia.氯氮平在首发精神分裂症治疗中的作用。
Am J Psychiatry. 2013 Feb;170(2):146-51. doi: 10.1176/appi.ajp.2012.12060778.
5
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.世界生物精神病学学会联合会（WFSBP）精神分裂症生物治疗指南，第 2 部分：2012 年关于精神分裂症长期治疗和抗精神病药引起的副作用管理的更新。
World J Biol Psychiatry. 2013 Feb;14(1):2-44. doi: 10.3109/15622975.2012.739708. Epub 2012 Dec 6.
6
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.世界生物精神病学学会联合会（WFSBP）精神分裂症生物治疗指南，第 1 部分：精神分裂症急性期治疗和治疗抵抗管理的 2012 年更新。
World J Biol Psychiatry. 2012 Jul;13(5):318-78. doi: 10.3109/15622975.2012.696143.
7
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.精神疾病患者的躯体疾病。一、患病率、药物影响和医疗保健差异。
World Psychiatry. 2011 Feb;10(1):52-77. doi: 10.1002/j.2051-5545.2011.tb00014.x.
8
Second-generation antipsychotics and constipation: a review of the literature.第二代抗精神病药物与便秘：文献综述。
Eur Psychiatry. 2011 Jan;26(1):34-44. doi: 10.1016/j.eurpsy.2010.03.003. Epub 2010 Jun 9.
9
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.2009 年精神分裂症 PORT 精神药理学治疗建议和总结陈述。
Schizophr Bull. 2010 Jan;36(1):71-93. doi: 10.1093/schbul/sbp116. Epub 2009 Dec 2.
10
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.危及生命的氯氮平所致胃肠道动力不足：102例分析
J Clin Psychiatry. 2008 May;69(5):759-68. doi: 10.4088/jcp.v69n0509.
Zotero 插件